Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent

(2010) Bin Bao et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Saccade velocity is reduced in presymptomatic spinocerebellar ataxia type 2

(2009) L. Velázquez-Pérez et al.   CLINICAL NEUROPHYSIOLOGY

Zinc in the physiology and pathology of the CNS

(2009) Stefano L. Sensi et al.   NATURE REVIEWS NEUROSCIENCE

Molecular epidemiology of spinocerebellar ataxias in Cuba: Insights into SCA2 founder effect in Holguin

(2009) Luis Velázquez Pérez et al.   NEUROSCIENCE LETTERS

Cognitive control of saccadic eye movements

(2008) S.B. Hutton   BRAIN AND COGNITION

Spinocerebellar ataxias caused by polyglutamine expansions: A review of therapeutic strategies

(2008) Benjamin R. Underwood et al.   CEREBELLUM

Zinc supplementation for the treatment or prevention of disease: Current status and future perspectives

(2008) Hajo Haase et al.   EXPERIMENTAL GERONTOLOGY